iBio, Inc. Common Stock Strategic Asset Allocation Index
iBio, Inc. Common Stock strategic asset allocation index. iBio, Inc. Common Stock (IBIO) has a Strategic Asset Allocation Index of 49.1% as of June 2023. Strategic assets (PP&E of $7.55 Million plus long-term investments of $-) total $7.55 Million, measured against net assets of $15.38 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IBIO net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of iBio, Inc. Common Stock (2009–2023)
Strategic asset allocation index of iBio, Inc. Common Stock from 2009 to 2023. This chart shows how iBio, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 15 annual periods from 2009 to 2023. As of June 2023, the index stands at 49.1%, representing strategic assets of $7.55 Million against net assets of $15.38 Million USD. Check iBio, Inc. Common Stock tangible net worth ratio to evaluate the tangible quality of the company's equity base.
iBio, Inc. Common Stock Strategic Asset Allocation Index by Year (2009–2023)
iBio, Inc. Common Stock strategic asset allocation index by year from 2009 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for iBio, Inc. Common Stock from 2009 to 2023, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of iBio, Inc. Common Stock.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 49.1% | $7.55 Million | $7.55 Million | $- | $15.38 Million | ▼ -16.7 pp |
| 2022 | 65.8% | $41.76 Million | $41.76 Million | $- | $63.48 Million | ▲ +33.8 pp |
| 2021 | 32.0% | $34.74 Million | $34.74 Million | $- | $108.57 Million | ▲ +25.5 pp |
| 2020 | 6.5% | $3.66 Million | $3.66 Million | $- | $56.61 Million | ▼ -985.8 pp |
| 2019 | 992.3% | $24.38 Million | $24.38 Million | $- | $2.46 Million | ▲ +836.7 pp |
| 2018 | 155.6% | $25.15 Million | $25.15 Million | $- | $16.16 Million | ▼ -131.4 pp |
| 2017 | 287.0% | $25.59 Million | $25.59 Million | $- | $8.91 Million | ▲ +180.7 pp |
| 2016 | 106.4% | $25.57 Million | $25.57 Million | $- | $24.04 Million | ▲ +106.2 pp |
| 2015 | 0.1% | $13.00K | $13.00K | $- | $11.23 Million | ▲ +0.0 pp |
| 2014 | 0.1% | $6.00K | $6.00K | $- | $6.10 Million | ▼ 0.0 pp |
| 2013 | 0.1% | $6.00K | $6.00K | $- | $5.07 Million | ▲ +0.1 pp |
| 2012 | 0.0% | $2.50K | $2.50K | $- | $6.17 Million | ▼ -4.5 pp |
| 2011 | 4.6% | $9.00K | $9.00K | $- | $196.64K | ▲ +3.6 pp |
| 2010 | 1.0% | $11.00K | $11.00K | $- | $1.08 Million | ▲ +0.7 pp |
| 2009 | 0.3% | $15.00K | $15.00K | $- | $4.39 Million | — |